Lafayette County Metro Narcotics said it has "no confirmed information" that kratom contributed to the deaths of two University of Mississippi students, even as toxicology results remain pending for up to two weeks. For clinicians, the case is a reminder that product detection does not establish causation — especially in polysubstance exposures that can quickly shape policy and patient perceptions before the evidence is in.

The Move

• Two Ole Miss students, Aidan Hamilton, 18, and Robert Strang, 20, were found dead Monday in separate locations, one on campus and one off campus.

• Investigators found packages of kratom at both scenes, but authorities have not determined whether kratom played any role in either death.

• Despite that uncertainty, several news outlets framed the deaths as suspected kratom overdoses before toxicology was complete.

Why It Matters for Care

• Patients may ask whether kratom itself is lethal; the current facts do not answer that question in these deaths.

• The CDC reported 233 kratom-associated deaths to poison centers from 2015 through 2025, but nearly 4 in 5 involved multiple substances.

• Opioids were involved in 62% of those cases, while benzodiazepines and stimulants each appeared in 20%, and alcohol in 19% — underscoring the need to assess for co-exposures, withdrawal management, and overdose risk broadly.

Between the Lines

• The policy fight is really about whether anecdotes will drive regulation of kratom and concentrated or semi-synthetic 7-hydroxymitragynine, or 7-OH, products.

• Some consumers use these products for chronic pain, opioid withdrawal, Anxiety disorder symptoms, or PTSD, while critics point to dependence risk and increasingly potent formulations.

• The clinical and political distinction matters: postmortem detection is not the same as a substance being determined to have caused death.

What to Watch

• The immediate milestone is the county coroner's toxicology report, which could take up to two weeks.

• At the federal level, the DEA said this summer it plans to temporarily place 7-OH above a certain concentration threshold into Schedule I.

• States are also moving on bans targeting 7-OH, kratom, or both — debates likely to intensify as more clinicians and lawmakers confront rising use and uncertain evidence.

Source: Reason